Inhalation in Medical News

FDA Approves TYVASO (Treprostinil) Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension

... (FDA) has approved TYVASO (treprostinil) inhalation Solution for the treatment of pulmonary arterial hypertension (PAH) using the TYVASO inhalation System (which includes the Optineb-ir device and ... (PMC) to modify certain aspects of the TYVASO inhalation System, perform a usability analysis and collect ...

Human Genome Sciences Announces Second-Quarter 2009 Financial Results and Key Developments

... to the FDA for raxibacumab for the treatment of inhalation anthrax. In July 2009, the FDA notified HGS that ... of raxibacumab in the event of life-threatening inhalation anthrax disease. The data published by the New ... includes novel drugs to treat hepatitis C, lupus, inhalation anthrax and cancer. The Company's ...

Perforomist Inhalation Solution data to be presented today at American Thoracic Society conference

... the use of Perforomist (formoterol fumarate) inhalation Solution in moderate to severe chronic ... San Diego. In one analysis, use of Perforomist inhalation Solution, when added to maintenance tiotropium, ... increased in those treated with Perforomist inhalation Solution twice daily compared with ...

Perforomist(R) Inhalation Solution Data in Patients With Moderate to Severe COPD to Be Presented at the International Conference of the American Thoracic Society

... the use of Perforomist(R) (formoterol fumarate) inhalation Solution in moderate to severe chronic ... San Diego. In one analysis, use of Perforomist inhalation Solution, when added to maintenance tiotropium, ... increased in those treated with Perforomist inhalation Solution twice daily compared with ...

Perforomist Inhalation Solution data to be presented at American Thoracic Society conference

... the use of Perforomist (formoterol fumarate) inhalation Solution will be featured in poster format at the ... Diego. In one analysis, use of Perforomist inhalation Solution, when added to maintenance tiotropium, ... increased in those treated with Perforomist inhalation Solution twice daily compared with ...

Dey, L.P. Highlights Perforomist(R) Inhalation Solution Data to Be Presented at the International Conference of the American Thoracic Society

... the use of Perforomist(R) (formoterol fumarate) inhalation Solution will be featured in poster format at the ... Diego. In one analysis, use of Perforomist inhalation Solution, when added to maintenance tiotropium, ... increased in those treated with Perforomist inhalation Solution twice daily compared with ...

PARI Pharma Receives 2nd ODD From EMEA; Moves Inhaled Tobramycin - eFlow Technology Program Forward

... we have seen a reduction to one fourth of the inhalation time for PARI Tobramycin 100 compared to TOBI. ... marked difference was a reduction in the average inhalation time to 4 - 4 1/2 minutes for the PARI Tobramycin ... Nebulizer System, approximately 10+ hours of inhalation time per month can be saved compared to TOBI. ...

Hope for preventative treatment for cystic fibrosis lung disease

... in a living organism. When mice are given inhalation treatment with the drug in the first days of ... screening could now benefit from the prophylactic inhalation therapy with amiloride. The physicians at the ... the therapeutic effects of preventive amiloride inhalation in future clinical trials. ...

Par Pharmaceutical Begins Shipment of Budesonide Inhalation Suspension Immediately

... Important information about budesonide inhalation suspension Budesonide inhalation suspension is indicated for the ... 12 months to 8 years of age. Budesonide inhalation suspension is not indicated for the relief of ...

PARI Pharma Completes Successful Clinical Trials for Tobramycin 100 & Investigational eFlow for CF

... marked difference was a reduction in the average inhalation time to 4 - 4 1/2 minutes for the PARI Tobramycin ... eFlow, approximately 10 hours+ per month of inhalation time can be saved compared to TOBI. "We believe ... lung deposition, less drug product, shorter inhalation times, and the chance to improve compliance - ...

Ozone-Depleting Inhalers Being Phased Out

... have been approved by the FDA: Proair HFA inhalation Aerosol; Proventil HFA inhalation Aerosol; and Ventolin HFA inhalation Aerosol. Also, an HFA-propelled inhaler ...

Concomitant use of Perforomist & tiotropium -- significant improvements -- COPD

... that concomitant therapy with Perforomist inhalation Solution (formoterol fumarate inhalation solution; FFIS), delivered by nebulization, and ... treatment with tiotropium alone. Perforomist inhalation Solution was approved in 2007 by the FDA for ...

Perforomist-comparable pharmacokinetic and pharmacodynamic profile to DPI formulation

... Society (ATS) demonstrate that Perforomist™ inhalation Solution (formoterol fumarate inhalation solution; FFIS) has a pharmacodynamic and ... Perforomist™ (formoterol fumarate) inhalation Solution, the only FDA-approved nebulized ...

Concomitant treatment with nebulized formoterol fumarate & tio-significant improvements -- COPD

... a combination of nebulized formoterol fumarate inhalation solution (Perforomist inhalation Solution) and tiotropium (TIO), compared to ... once-daily treatment with tiotropium bromide inhalation powder (TIO; Spiriva, 18 g) administered with a ...

Clinical Trial Data for Perforomist(TM) Inhalation Solution to be Presented at ATS on May 20, 2008

... fumarate. Perforomist(TM) (formoterol fumarate) inhalation Solution was approved in 2007 by the FDA for ... the research results. About Perforomist(TM) inhalation Solution Indication Perforomist(TM) inhalation Solution is indicated for the ...

PharmAthene and Medarex Announce Additional $0.8 Million U.S. Government Appropriation for Continued Development of Anthrax Therapeutic Valortim(TM)

... to protect against anthrax infection, including inhalation anthrax, the most lethal form of illness in ... exposure. The serious forms of human anthrax are inhalation anthrax, cutaneous anthrax, and intestinal anthrax. Initial symptoms of inhalation anthrax infection may resemble a common cold. ...

Triumph-1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint

... endpoint. The TRIUMPH-1 (TReprostinil Sodium inhalation Used in the Management of Pulmonary Arterial ... by the trial protocol as 10-60 minutes after inhalation of Viveta, relative to baseline. Preliminary ... trial protocol as a minimum of four hours after inhalation of Viveta, for treatment change in 6MW distance ...

Clinical trial data: Safety/efficacy of concomitant formoterol fumarate/tiotropium treating COPD

... of nebulized formoterol fumarate is Perforomist inhalation Solution, which is indicated for long-term, ... years of worldwide experience. Perforomist inhalation Solution is the first and only FDA-approved ... of tiotropium alone. For physicians, Perforomist inhalation Solution and commonly prescribed long-acting ...

PARI Granted US Patent for Vortex Holding Chamber

... holding chamber with a one piece, dual-valve system that optimizes patient inhalation and exhalation for more efficient medication delivery with a metered dose ... minimizes drug delivered to the throat, and allows low resistance inhalation and exhalation with the device," added Geoff A. Hunziker, president of ...

New Drug Fights Anthrax Toxin

... showed that a single dose of raxibacumab was an effective treatment for inhalation anthrax in both rabbits and monkeys. The drug provided a significant ... and could be used in a clinical setting in cases of life-threatening inhalation anthrax disease, Bolmer said. Under a contract with U.S. Biomedical ...

Advanced Life Sciences Announces Posting of Briefing Documents for FDA Advisory Committee Meeting on Restanza(TM) (cethromycin)

... Restanza(TM) is also being investigated for the prophylactic treatment of inhalation anthrax post-exposure. The FDA has designated Restanza(TM) as an orphan drug for the prophylactic treatment of inhalation anthrax post exposure, but the drug is not yet approved for this or any ...

Advanced Life Sciences Announces First Quarter 2009 Financial Results and Financial Outlook

... cethromycin is also being investigated for the prophylactic treatment of inhalation anthrax post-exposure. The FDA has designated cethromycin as an orphan drug for the prophylactic treatment of inhalation anthrax post exposure, but the drug is not yet approved for this or any ...

American Association for Homecare Applauds Senate Subcommittee Efforts to Prevent Waste and Fraud in Medicare; Association Presents 13-Point Legislative Plan to Stop Waste and Fraud

... power wheelchairs and other mobility assistive technologies, oxygen and inhalation drug therapy, home infusion, hospital beds, diabetic supplies, and other ... equipment and therapy, mobility assistive technologies, medical supplies, inhalation drug therapy, home infusion, and other medical equipment and services in ...

Swallowing-Breathing Dysfunction Worsens Lung Disorder

... air pressure below the vocal folds during a swallow and prevents inhalation of food residue after swallowing," Gross said in the news release. "In ... breathing timing were disrupted such that swallows were occurring during inhalation or were followed by inhalation," she said. "COPD patients also swallowed ...

U.S. Department of Defense Exercises $2.0 Million Option to Fund Cethromycin Development

... in biodefense beyond the success that was demonstrated in preventing inhalation anthrax," stated Dr. Michael T. Flavin, chairman and chief executive ... designated cethromycin as an orphan drug for the prophylactic treatment of inhalation anthrax post-exposure, but the FDA has not yet approved the drug for ...

Scott Miller and Company Premieres "A CALL TO ARMS 2009 EDITION" at the Camelot Theaters in Palm Springs

... the anthrax vaccine has never been approved for the prevention of human inhalation anthrax disease. The FDA has approved the anthrax vaccine as ... 2005 and 2008, but has not approved the anthrax vaccine as a prevention to inhalation anthrax disease. There is no proof that persons exposed to aerosolized ...

Ample Supplies of Relenza Available as Flu Season Peaks

... supplies of the influenza antiviral medication RELENZA(R) (zanamivir) inhalation Powder ( www.RELENZA.com ) to meet public health needs as the current ... rather than simply masking the symptoms. RELENZA is delivered via oral inhalation using a Diskhaler. Step-by-step instructions for proper use of the ...

UB-designed ventilator can safely sedate ICU patients for less

... designed to cost effectively deliver to patients small amounts of powerful inhalation anesthetic agents as they breathe or are mechanically ventilated. The ... intravenous sedatives combined with precisely controlled concentrations of inhalation agents delivered by an expensive, specially designed anesthesia ....

LegalView Informs Readers of New Criminal Probe Involving Peanut Butter Recall Salmonella Poisonings

... Mesothelioma is a deadly form of lung cancer that has been linked to the inhalation of asbestos fibers and asbestos dust. Following initial inhalation of the asbestos, a victim may be unaware of the cancerous cells beginning ...

MINRAD Receives Notice of Failure to Satisfy a Continued Listing Rule from NYSE Alternext

... anesthesia and analgesia business currently manufactures and sells generic inhalation anesthetics that are used for human and veterinary surgical procedures. ... a drug /drug delivery system for the use of halogenated ethers as inhalation analgesics for conscious sedation. Forward-Looking Statements ...

Asthma 'Rescue' Inhalers Are Changing

... lot of people who say the inhalers aren't working may not be using proper inhalation technique," said Nancy Sander, president of the Allergy and Asthma Network Mothers of Asthmatics. "It's your inhalation that carries your medicine where it needs to go. So, start to breathe in ...

PARI Pharma Unveils Closed System Using eFlow Technology at Medical Plastics Conference

... dose uniformity and hygiene. "This is a very exciting period in inhalation drug development. Building on our ability to customize a delivery device ... such as eFlow Technology. PARI Pharma provides comprehensive inhalation drug development, including nebulizer formulation development and ...

Advanced Life Sciences and Wyeth Sign Commercialization Agreement for Cethromycin in Asia Pacific Region

... cethromycin is also being investigated for the prophylactic treatment of inhalation anthrax post-exposure and other pathogens of bioterror including ... designated cethromycin as an orphan drug for the prophylactic treatment of inhalation anthrax post-exposure, but the drug is not yet approved for this or any ...

MAP Pharmaceuticals Acquires Proprietary Drug Particle Formulation Technology From Eiffel/Telesso Technologies Limited

... the development of numerous inhaled multi-drug combination and biologic inhalation products, in addition to our MAP0005 combination inhaled ... by currently available medicines. The company applies its proprietary inhalation technologies to enhance the therapeutic benefits and commercial ...

MINRAD International, Inc. Announces FDA Approval of Petrem(TM) Sevoflurane

... Center for Veterinary Medicine to market Petrem(TM) (Sevoflurane) inhalation anesthetic. This week they have initiated their US product launch to the ... exposure. MINRAD International also manufactures and markets generic inhalation anesthetics for use in connection with human and veterinary surgical ...

Florida EMS and fire vehicles to stock Cyanokit 5g antidote for cyanide poisoning

... in fire smoke, may play a significant role in causing the deaths of smoke inhalation victims. In the United States, smoke inhalation is responsible for up to 10,000 civilian and firefighter deaths and more ...

Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50

... The use of Advair Diskus(R) 500/50 (fluticasone propionate and salmeterol inhalation powder) was associated with the lowest number of cardiovascular adverse ... Diskus 250/50 has not been demonstrated. Patients should only take one inhalation of Advair twice a day. People with COPD taking Advair may have a higher ...

Human Genome Sciences Appoints John L. Lamattina, Ph.D., to Its Board of Directors

... development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax, cancer and other immune-mediated diseases. The Company's primary ... (raxibacumab) is in late-stage development for the treatment of inhalation anthrax, and the Company is on track to begin the delivery in fall 2008 of ...

FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD

... Diskus(R) 250/50 (fluticasone propionate 250 mcg and salmeterol 50 mcg inhalation powder) for the reduction of exacerbations in patients with chronic ... Diskus 250/50 has not been demonstrated. Patients should only take one inhalation of Advair twice a day. People with COPD taking Advair may have a higher ...

RxElite Awarded Anesthetic Gases Multi-Source Contract by Premier Inc., a Purchasing Network for More than 1,500 U.S. Hospitals and 49,000 Other Healthcare Sites

... areas of anesthesia and sterile liquid dose drugs (including respiratory inhalation drugs, ophthalmics, and injectable drugs). About Premier, Inc., 2006 ... exposure. Minrad International also manufactures and markets generic inhalation anesthetics for use in connection with human and veterinary surgical ...